Currently, transport and storage of organs is largely in common isothermal refrigerators (picnic), and there is no mechanism to preserve in good condition the state of organ preservation in static conditions from extraction to implantation. This results in low efficiency and therefore increased spending in the medium and long-term national health systems.
Transplant Biomedicals is developing an innovative and unique technology that prevents injuries that occur during the transport of the organs for transplantation. It allows comprehensive conservation and reduces ischemia for a longer period of time, thereby increasing the viability of the grafts.
"This new injection of capital will allow us to accelerate the development of this pioneering medical technology, both in hospitals and laboratories. Our goal is to start marketing the system between 2017 and 2018 and access to a market that represents more than 160 million euros. At the same time, we want to increase the number of viable organs worldwide and contribute ultimately to save lives," explains Ignasi Heras, CEO and cofounder of the spin-off.
"The use of the new device behave hospital savings of between 5% and 10% for transplantation, mainly due to fewer re-hospitalizations, decreased waiting lists and reducing the cost of transportation for urgent media," he says Dr. Carmen Peralta, co-founder of the spin-off and Head of the Research Group Protective Strategies Against hepatic ischemia-reperfusion injury of IDIBAPS.